Concurrent OX40 and CD30 Ligand Blockade Abrogates the CD4-Driven Autoimmunity Associated with CTLA4 and PD1 Blockade while Preserving Excellent Anti-CD8 Tumor Immunity-Reference-Cited by-同舟云学术

Concurrent OX40 and CD30 Ligand Blockade Abrogates the CD4-Driven Autoimmunity Associated with CTLA4 and PD1 Blockade while Preserving Excellent Anti-CD8 Tumor Immunity

Published:2017-06-23 Issue:3 Volume:199 Page:974-981
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Nawaf Maher G.,Ulvmar Maria H.^ORCID,Withers David R.,McConnell Fiona M.^ORCID,Gaspal Fabrina M.,Webb Gwilym J.^ORCID,Jones Nick D.,Yagita Hideo,Allison James P.,Lane Peter J. L.^ORCID

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference36 articles.

1. Emerging patterns of somatic mutations in cancer

2. Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma

3. The thymic medulla is required for Foxp3+ regulatory but not conventional CD4+ thymocyte development

4. Aire-Dependent Thymic Development of Tumor-Associated Regulatory T Cells

5. CTLA-4 Control over Foxp3 + Regulatory T Cell Function

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. OX40 and OX40L Interaction in Cancer;Current Medicinal Chemistry;2021-09-09

2. Blockade of tumor necrosis factor superfamily members CD30 and OX40 abrogates disease activity in murine immune-mediated glomerulonephritis;Kidney International;2021-08

3. CD30+OX40+ Treg is associated with improved overall survival in colorectal cancer;Cancer Immunology, Immunotherapy;2021-02-02

4. PD‑L1/PD‑1 blockade in breast cancer: The immunotherapy era (Review);Oncology Reports;2020-11-03

5. Immune checkpoint modulation enhances HIV-1 antibody induction;Nature Communications;2020-02-19